Judge blocks HHS rule requiring drug prices in TV ads

A federal judge has blocked an HHS rule that would force pharmaceutical companies to include the list prices of their drugs in direct-to-consumer advertisements, according to CNBC.

U.S. District Judge Amit Mehta ruled July 8 that the Trump administration doesn't have the authority to issue the rule, effectively preventing the rule from taking effect July 9 as planned. 

The rule was announced in May as part of President Donald Trump's blueprint to lower prescription drug costs in the U.S. 

Under the rule, drugmakers would have to include the list price of their drugs if a month's supply  cost $35 or more.

Three major drugmakers, Merck, Eli Lilly and Amgen, filed a lawsuit to block the rule on June 14, arguing that the rule would confuse customers and it violated drugmakers' freedom of speech. 

Access the full report here.

More articles on pharmacy:
Walmart cutting some pharmacy jobs
UPMC acquires community pharmacy in Pittsburgh
Oklahoma judge approves Teva's $85M opioid settlement

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers